SEATTLE -- (BUSINESS WIRE) -- Natural Molecular Testing Corp. (NMTC), a company providing groundbreaking clinical molecular testing and services in the medical genomics field, today announced the formation of its new Medical Advisory Board. The board will convene with NMTC executives in Atlanta February 5-6th.
NMTC, a privately-owned company, provides personalized medicine testing that identifies a patient’s genetics and provides physicians with guidance in prescribing and dosing medications for more safe and effective treatment.
The board consists of a group of multi-disciplinary and highly respected clinicians, practitioners and thought leaders under the leadership of NMTC’s CMO Karthikeshwar Kasirajan, MD. The advisory board will meet with NMTC officers and executives at intervals to provide feedback, input and guidance on the company’s initiatives and their implementation.
“As luminaries in their respective fields, each of these board members will provide significant perspectives and experience,” said NMTC Chief Executive Officer Beau R. Fessenden. “In addition to ongoing guidance, they will play an important role in expanding pathways to communicate with fellow healthcare professionals about the role of clinical molecular testing.”
Members of NMTC’s newly-formed Medical Advisory Board include:
Marc E. Agronin, M.D., is an adult and geriatric psychiatrist who has served since 1999 as the Medical Director for Mental Health and Clinical Research at the Miami Jewish Health Systems (MJHS), Florida's largest long-term care institution.
Stephen G. Ellis, MD, is the Section Head of Invasive/Interventional Cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at the Cleveland Clinic. He also is co-director and co-founder of the Cardiovascular Genebank.
F. Michael Gloth, III, MD, is Chief Medical Officer for Moorings Park Healthy Living in Naples, FL. and Associate Professor of Medicine in the Division of Geriatric Medicine and Gerontology at Johns Hopkins University School of Medicine.
George T. Grossberg, MD, is a member of the Neurology & Psychiatry Department at Saint Louis University. He is a former President of the American Association of Geriatric Psychiatry and the International Psychogeriatric Association (IPA).
John R. Horn, Pharm. D., FCCP, is Professor of Pharmacy and Associate Director of the University of Washington Medicine Pharmacy Services. His areas of research include drug interactions, cardiovascular and gastrointestinal therapeutics, and pharmacokinetics.
Russell Samson, MD, is affiliated with Sarasota Vascular Specialists of Sarasota, FL, and is a Clinical Associate Professor of Surgery (Vascular) at Florida State University Medical School. He was elected as a Distinguished Fellow of the Society for Vascular Surgery.
Warren Strickland, MD, is the Medical Director of Cardiology for the Huntsville Hospital System in Huntsville, Alabama. Dr. Strickland is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.
Kathryn Teng, MD, FACP, is Director of the new Center for Personalized Healthcare at the Cleveland Clinic, where she will lead initiatives incorporating personalized healthcare approaches with tailored care plans for patients.
Frank Veith, MD, is The William J. von Liebig Chair in Vascular Surgery and Professor of Surgery at The Cleveland Clinic and New York University Medical Center. He is currently the chairman of the American Board of Vascular Surgery.
About Natural Molecular Testing Corp. (NMTC)
Natural Molecular Testing Corporation (NMTC) is a privately-owned, high-complexity molecular testing facility. NMTC provides genetic testing services and resources for our clinical partners to assist them in better caring for their patients by advancing patient care through the latest breakthroughs in genomic technology.
For more information about Natural Molecular Testing Corp., visit www.naturalmolecular.com